RonaldDAlvarezMD
Obstetrics & Gynecology • Nashville, TNGynecologic Oncology
Associate Professor of Obstetrics & Gynecology, University Alabama
Dr. Alvarez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000
Summary
- Professor and Director, Divison of Gynecologic Oncology
Education & Training
University of Alabama Medical CenterFellowship, Gynecologic Oncology, 1987 - 1990- University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 1983 - 1986
Louisiana State University School of Medicine in New OrleansClass of 1983
Certifications & Licensure
AL State Medical License 1984 - 2025
TN State Medical License 2016 - 2025
FL State Medical License 2018 - 2020
LA State Medical License 1983 - 2019- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Fellow (FACS) American College of Surgeons
- Join now to see all
Clinical Trials
- Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer Start of enrollment: 2005 Aug 01
- Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer Start of enrollment: 2005 Nov 01
- Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer Start of enrollment: 2007 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.Joyce Liu, Andrew Berchuck, Floor J Backes, Joshua Cohen, Rachel Grisham
Journal of the National Comprehensive Cancer Network. 2024-10-01 - Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift.Mohammed N Tantawy, J Oliver McIntyre, Fiona Yull, M Wade Calcutt, Dmitry S Koktysh
Cancer Medicine. 2024-02-01 - Navigating an equitable course on more challenging roads: a response.Ronald D Alvarez, Donna D Johnson, Eve Espey
American Journal of Obstetrics and Gynecology. 2024-01-01
Authored Content
- Re-Engineering Academic Departments of Obstetrics and Gynecology to Operate in a Pandemic World and Beyond – A Joint AGOS/CUCOG StatementJune 2020
Press Mentions
The Misery of Ragweed Season; Safe Firearms Storage to Protect Children; Shingles in People Under 50; Plus Other News Stories with VUMC SourcesSeptember 13th, 2024- New Study in JNCCN Presents Evidence for ‘Tough Conversations’ Around Racism in Access to Cancer CareNovember 8th, 2022
- Vanderbilt University Medical Center Named to U.S. News ‘Honor Roll’ of Best HospitalsAugust 3rd, 2021
- Join now to see all
Grant Support
- A Phase I Trial To Assess The Safety And Immunogenicity Of Repeated, Cluster PARTNational Cancer Institute2009–2011
- Infectivity Enhanced Virotherapy For Ovarian CancerNational Cancer Institute2007–2008
- Enhanced Adenoviral Vectors For Ovarian CancerNational Cancer Institute2001–2007
- Ovarian Cancer Gene Therapy Midcareer Clinical ScientistNational Cancer Institute1999–2003
- Molecular Chemotherapy For Ovarian CancerNational Cancer Institute1998–1999
- Phase II Clinical Trial Of SulindacDivision Of Cancer Prevention And Control1996–1999
- Single Chain Gene Therapy Of Ovarian CancerNational Cancer Institute1996–1997
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
